NIH

FDA Grants AppliedVR Breakthrough Designation for Virtual Reality Chronic Pain Treatment

by Nile
October 21, 2020

What You Should Know: – FDA awards AppliedVR Breakthrough Device designation for treating treatment-resistant fibromyalgia and chronic intractable lower back pain – AppliedVR’s EaseVRx program helps patients learn self-management skills grounded in evidence-based cognitive-behavioral therapy (CBT) principles and other behavioral methods. AppliedVR, a pioneer advancing… Read More »FDA Grants AppliedVR Breakthrough Designation for Virtual Reality Chronic Pain Treatment

¿Pueden los pacientes de COVID tener el tratamiento de Trump? Está bien preguntar

by Nile
October 20, 2020

Cuando Terry Mutter se despertó con dolor de cabeza y músculos adoloridos, el levantador de pesas amateur lo atribuyó a un entrenamiento duro. Sin embargo, ese miércoles a la noche tuvo 101 grados de fiebre y estaba claramente enfermo. “Me sentía como si me hubiera… Read More »¿Pueden los pacientes de COVID tener el tratamiento de Trump? Está bien preguntar

Can Ordinary COVID Patients Get the Trump Treatment? It’s OK to Ask

by Nile
October 20, 2020

When Terry Mutter woke up with a headache and sore muscles on a recent Wednesday, the competitive weightlifter chalked it up to a hard workout. By that evening, though, he had a fever of 101 degrees and was clearly ill. “I felt like I had… Read More »Can Ordinary COVID Patients Get the Trump Treatment? It’s OK to Ask

NIH Funds First Nationwide Rare and Atypical Diabetes Network

by Nile
October 2, 2020

What You Should Know: – NIH awards funding for Rare and Atypical Diabetes Network, or RADIANT that will seek to discover the cause of several unusual forms of diabetes. – RADIANT plans to screen about 2,000 people with unknown or atypical forms of diabetes that… Read More »NIH Funds First Nationwide Rare and Atypical Diabetes Network

NIH Taps PhysIQ to Develop AI-Based COVID-19 Digital Biomarker

by Nile
September 30, 2020

What You Should Know: – physIQ has been selected by the National Institute of Health (NIH) to develop an innovative AI-based COVID-19 digital biomarker solution to address the COVID-19 pandemic. – Early detection of COVID-19 decompensation in patients is complicated by infrequent and non-specific clinical… Read More »NIH Taps PhysIQ to Develop AI-Based COVID-19 Digital Biomarker

Report: FDA halted move to authorize convalescent plasma for Covid-19 over evidence concerns

by Nile
August 20, 2020

The New York Times reported that the FDA was prepared to issue an emergency use authorization for the treatment last week, but NIH Director Francis Collins and NIAID Director Anthony Fauci intervened, arguing that data were too weak.

Turning Anger Into Action: Minority Students Analyze COVID Data on Racial Disparities

by Nile
August 13, 2020

As the coronavirus swept into Detroit this spring, Wayne State University junior Skye Taylor noticed something striking. On social media, many of her fellow Black classmates who live or grew up in the city were “posting about death, like, ‘Oh, I lost this family member… Read More »Turning Anger Into Action: Minority Students Analyze COVID Data on Racial Disparities

Talis Awarded $25M NIH Contract for Point-of-Care COVID-19 Testing

by Nile
August 4, 2020

What You Should Know: – Today, Talis Biomedical Corporation announced it has been awarded a $25M contract from the National Institutes of Health (NIH) as part of Phase 2 of its Rapid Acceleration of Diagnostics (RADx) initiative as well as another $100 million in additional… Read More »Talis Awarded $25M NIH Contract for Point-of-Care COVID-19 Testing

Don’t Fall for This Video: Hydroxychloroquine Is Not a COVID-19 Cure

by Nile
July 31, 2020

Millions of people, including the president of the United States, have seen or shared a video in which a doctor falsely claims there is a cure for the coronavirus, and it’s a medley starring hydroxychloroquine. The video shows several doctors in white coats giving a press conference… Read More »Don’t Fall for This Video: Hydroxychloroquine Is Not a COVID-19 Cure

Ciox Health Acquires Biomedical NLP Company Medal

by Nile
July 28, 2020

What You Should Know: – Ciox Health has acquired Medal, Inc., a biomedical Natural Language Processing (biomed-NLP) technology company. – The acquisition will lead Ciox to better and more quickly enable real-world data in support of research that advances patient care. Ciox Health, a leading health… Read More »Ciox Health Acquires Biomedical NLP Company Medal

Eko Awarded $2.7M NIH Grant for Heart Murmur & Valvular Heart Disease Detection Algorithms

by Nile
July 22, 2020

What You Should Know: – The National Institutes of Health (NIH) has granted next-generation cardiac AI company Eko an award totaling $2.7 million to support continued collaborative work with Northwestern Medicine Bluhm Cardiovascular Institute – The grant will focus on validating algorithms and help more… Read More »Eko Awarded $2.7M NIH Grant for Heart Murmur & Valvular Heart Disease Detection Algorithms

NIH Project Homes In on COVID Racial Disparities

by Nile
July 21, 2020

While the disproportionate impact of COVID-19 on Black and Hispanic Americans is no secret, federal officials have launched studies of the disparity that they hope will better prepare the country for the next great epidemic. The National Institutes of Health began the ambitious “All of… Read More »NIH Project Homes In on COVID Racial Disparities

HHS Taps Fenway Health as Pilot Site for Precision Medicine Project

by Nile
July 14, 2020

What You Should Know: – Fenway Health has been selected as the pilot site to participate in the Advancing Standards for Precision Medicine (ASPM) project. – The ASPM project is focused on how healthcare providers can systematically identify the socio-economic factors that may impact the… Read More »HHS Taps Fenway Health as Pilot Site for Precision Medicine Project

NIAID launches clinical trial network for preventive drugs, vaccines against Covid-19

by Nile
July 9, 2020

The NIAID create the Covid-19 Prevention Trials Network by combining four existing ones, primarily focused on HIV and AIDS, which will continue that work in addition to their new focus on Covid-19.